Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search by country: Russian Federation
Woman and Man Max 99 years
nct
Update Il y a 3 ans
A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder
The purpose of the study is to assess whether treatment with SR58611A can prevent relapse of depressive symptoms in patients with major depressive disorder. Relapse will be assessed using ...
Country
Argentina
,
Bulgaria
,
Croatia
,
Czech Republic
,
Finland
,
France
,
Mexico
,
Poland
,
Romania
,
Russian Federation
,
Serbia
,
Slovakia
,
South Africa
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
nct
Update Il y a 3 ans
Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients
In order to obtain information on a wider range of doses of GW642444 (a possible new medication to treat asthma) than has been previously examined in asthmatic patients, this current study...
Country
Germany
,
New Zealand
,
Russian Federation
,
Sweden
,
United Kingdom
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
nct
Update Il y a 3 ans
A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status
This multi-center, single-arm study will evaluate the efficacy and safety of rituximab in combination with fludarabine and cyclophosphamide in participants with B-cell chronic lymphocytic ...
Country
Russian Federation
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
nct
Update Il y a 3 ans
A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic Impairment
The purpose of this study is to evaluate the impact of hepatic dysfunction on the pharmacokinetics and safety of LY2624803 and its major metabolite, LSN2797276.
Country
Germany
,
Hungary
,
Russian Federation
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
nct
Update Il y a 3 ans
Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia
This is an study to evaluate the safety, efficacy, and tolerability of RGH-188 relative to placebo in adult patients (18-60 years of age) with acute exacerbation of schizophrenia.
Country
India
,
Malaysia
,
Russian Federation
,
Ukraine
,
United States
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
nct
Update Il y a 3 ans
Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia
The purpose of this study is to evaluate the efficacy of TAK-583, once daily (QD), in relieving pain in subjects with postherpetic neuralgia.
Country
Australia
,
Bulgaria
,
Czech Republic
,
Germany
,
Netherlands
,
Poland
,
Russian Federation
,
South Africa
,
United Kingdom
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
nct
Update Il y a 3 ans
Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
This randomized, open-label, crossover study will evaluate participants' preference and healthcare professional (HCP) satisfaction with SC versus IV Herceptin administration in HER2-positi...
Country
Canada
,
Denmark
,
France
,
Germany
,
Italy
,
Poland
,
Russian Federation
,
Spain
,
Sweden
,
Switzerland
,
Turkey
,
United Kingdom
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
nct
Update Il y a 3 ans
An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin
This is an open-label dose escalation trial using ABI-007 plus carboplatin.
Country
Russian Federation
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
nct
Update Il y a 3 ans
A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)
The major purpose of the study is to help determine whether giving the combination of Elzasonan with Zoloft to people with depression is a better treatment than taking Zoloft alone. This s...
Country
Chile
,
Estonia
,
Russian Federation
,
United States
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
nct
Update Il y a 3 ans
Complications in Hypertension and Obesity
The study in aimed to investigate epidemiology of risk factors in Russian Federation its prognostic value aimed on acceptance of national specific definition of metabolic syndrome and guid...
Country
Russian Federation
organs
None
Specialty
None
Opened trial
More information
1
2
3
4
5
6
7
8
9
10
Next